TYZEKA(TM) (telbivudine) Approved By U.S. Food And Drug Administration (FDA) As A New Treatment For Patients With Chronic Hepatitis B

Thu, 26 Oct 2006 12:00 PM EST

... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) today announced the approval of TYZEKA(TM) (telbivudine) by the U.S. Food and Drug Administration (FDA) as a new once-a-day oral treatment, taken with or without food, for patients with chronic hepatitis B (CHB). [click link for full article] ...